CN111821363A - Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof - Google Patents
Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof Download PDFInfo
- Publication number
- CN111821363A CN111821363A CN202010678719.6A CN202010678719A CN111821363A CN 111821363 A CN111821363 A CN 111821363A CN 202010678719 A CN202010678719 A CN 202010678719A CN 111821363 A CN111821363 A CN 111821363A
- Authority
- CN
- China
- Prior art keywords
- verruca
- liquid dressing
- percent
- liquid
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a liquid dressing applied to superficial wound and peripheral skin care and an application method thereof, which are applied to the field of medicines, and the liquid dressing comprises the following components in percentage by mass: 60 to 81.7 percent of dry distillation liquid of hawthorn seeds, 10 to 18 percent of acetic acid, 6 to 17 percent of heptaldehyde, 0.6 to 1.8 percent of dimethoxyphenol, 0.8 to 1.5 percent of mint essence and 0.9 to 1.7 percent of aloe. The liquid dressing can be used for nursing superficial wound surfaces and surrounding skin of people such as condyloma acuminatum, verruca vulgaris, verruca plana, verruca filiformis, verruca plantaris, herpes and the like, and has a certain treatment effect, a user can operate the liquid dressing according to guidance, the limitation of a treatment process is avoided, the operation and application flexibility is improved, the treatment pain of a patient is reduced, and the comfort level of a diagnosis and treatment process is improved. In addition, the components of the liquid dressing are safe and low in sensitization rate, secondary damage to affected parts is avoided, the use and nursing effects are guaranteed, the immune system is improved, and the skin mucosa is repaired, so that diseases are not easy to relapse.
Description
Technical Field
The invention relates to the field of medicines, in particular to a liquid dressing applied to superficial wound and peripheral skin care and an application method thereof.
Background
Herpes and warts are common infectious diseases, both caused by corresponding viral infections. Eight viruses in the herpes virus family are currently known to cause human disease, and such viruses are collectively referred to as Human Herpes Viruses (HHV). HHV is a group of medium-sized DNA viruses with envelope, can cause various diseases of human beings, can remain in the body for a long time, and can cause recurrent infection under certain conditions. The common diseases in clinic include chicken pox, herpes zoster, herpes simplex, genital herpes and the like, can invade a plurality of organs of a human body, and can be attacked at any age. The common treatment method is the application of calamine lotion and ointment, and the simultaneous oral administration of medicines can also be carried out. Warts are skin surface neoplasms caused by human papilloma virus, are mostly seen in children and young adults, have a latency period of 1-3 months, and can be inoculated and spread by themselves. The virus exists in acanthocyte, and can promote cell proliferation to form verrucous lesion. According to the clinical manifestations and the parts, the medicine is divided into verruca vulgaris, verruca plana, verruca plantaris, genital wart (condyloma acuminatum), oral wart, sore throat wart and epidermodysplasia verruciformis. The virus can be transmitted by direct or indirect contact, the perianal and genital warts are mostly transmitted by sexual contact, and trauma or skin damage are important factors of HPV infection. Warts are usually treated with cryo-laser. However, although the therapeutic effect of this method is very good, multiple freezing operations are usually required to ensure the freezing removal effect during the treatment period, and at this time, the patient is subjected to pain and may have recurrence, which increases the physical and economic burden of the patient, and requires professional personnel to perform the operation, which has certain time and place diagnosis and treatment limitations.
Disclosure of Invention
The technical problem to be solved by the invention is to provide the liquid dressing applied to superficial wound surface and peripheral skin nursing, which improves the treatment flexibility and the convenience.
The technical scheme adopted by the invention for solving the technical problems is as follows:
a liquid dressing applied to superficial wound surfaces and peripheral skin care comprises the following components in percentage by mass: 60-81.7% of dry distillation liquid of hawthorn seeds, 10-18% of acetic acid, 6-17% of heptaldehyde, 0.6-1.8% of dimethoxyphenol, 8-15% of mint essence and 9-17% of aloe.
A use method of a liquid dressing applied to superficial wound surface and peripheral skin care comprises the following operation steps:
(1) preparing a liquid dressing formed according to the proportion of the liquid dressing applied to superficial wound surface and peripheral skin nursing;
(2) dipping and soaking the liquid dressing prepared in the step (1) by using a cotton swab, coating the liquid dressing on an affected part by using the cotton swab, and applying the cotton swab dipped with the liquid dressing on the affected part and pressing for 3-8 minutes;
(3) daubing the surface of an affected part with erythromycin;
(4) a single coating operation is completed.
Further, the affected part in the step (2) comprises condyloma acuminatum, herpes, verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris, the pressing time is 3 to 5 minutes when the affected part is condyloma acuminatum and herpes, and the pressing time is 5 to 8 minutes when the affected part is verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris.
Further, when the affected part is condyloma acuminatum and herpes, the operation frequency of the step (2) is once a day, and when the wound surface is verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris, the operation frequency of the step (2) is twice a day.
The invention has the beneficial effects that:
1. the liquid dressing can be used for nursing superficial wound surfaces and peripheral skin of people such as condyloma acuminatum, verruca vulgaris, verruca plana, verruca filiformis, verruca plantaris, herpes eruptions and the like, and has a certain treatment effect, the limitation of time and space in the treatment process is avoided, a user can operate the liquid dressing according to guidance, the operation and application flexibility is improved, the treatment pain of a patient is reduced, and the comfort level in the diagnosis and treatment process is improved. In addition, the components of the liquid dressing are safe and low in sensitization rate, secondary damage to the affected part is avoided, and the use and nursing effects are guaranteed.
2. The Crataegus cuneata pit dry distillation liquid has the effects of detoxifying, clearing damp, killing parasites and relieving itching, is matched with the mint essence to realize emulsification and smell pressing operation, improves moistening and penetrating effects, and is matched with the aloe to promote healing, diminish inflammation, sterilize and regenerate immunity to further improve the quality of the dressing. Meanwhile, the liquid dressing can form a layer of protective liquid film on the outside of the wound, so that the wound is protected, external pathogenic bacteria are prevented from invading, the killing effect on surrounding pathogenic bacteria can be realized, the healing of the wound is further promoted, and the infection is prevented.
3. This application method of liquid dressing is simple and convenient, and easily most patients' effective use has guaranteed the effect of using medicine by oneself, and distinguishes the operation according to the affected part of different properties, has guaranteed treatment when guaranteeing to use medicine comfort level, has promoted the treatment standardization.
Detailed Description
The present invention will be further described with reference to the following embodiments.
The first embodiment is as follows:
a liquid dressing applied to superficial wound surfaces and peripheral skin care is characterized by comprising the following components in percentage by mass: 60% of dry distillation liquid of hawthorn seeds, 18% of acetic acid, 17% of heptaldehyde, 1.8% of dimethoxyphenol, 15% of mint essence and 17% of aloe.
Example two:
a liquid dressing applied to superficial wound surfaces and peripheral skin care is characterized by comprising the following components in percentage by mass: 72.3 percent of hawthorn seed dry distillation liquid, 13 percent of acetic acid, 11 percent of heptaldehyde, 1.5 percent of dimethoxyphenol, 11 per mill of mint essence and 11 per mill of aloe.
Example three:
a liquid dressing applied to superficial wound surfaces and peripheral skin care is characterized by comprising the following components in percentage by mass: 81.7% of dry distillation liquid of hawthorn seeds, 10% of acetic acid, 6% of heptaldehyde, 0.6% of dimethoxyphenol, 8% of mint essence and 9% of aloe.
Meanwhile, for ensuring the product quality, the components can be extracted and processed by using a super-wet extraction technology according to requirements, so that the quality of the components is ensured and the overall performance of the liquid dressing is improved more easily. This super wet extraction technique of liquid dressing can make up the adjustment according to the characteristic of raw materials and product demand, has advantages such as high efficiency, environmental protection, safety and assurance active ingredient activity, and application scope is fairly extensive, can ensure the activity of active ingredient in the natural thing simultaneously, avoids harmful human solvent's use to extract the separation with economic mode, can fully remain its active ingredient and smell simultaneously, provides the guarantee for the whole effect of product. In addition, the following toxicology tests were carried out on the liquid dressing:
(1) test results of acute oral toxicity test: a non-toxic grade;
(2) the vagina mucosa stimulation test detection result: no irritation;
(3) the mouse marrow pleochromocyte micronucleus test detection result is as follows: is negative;
(4) skin irritation test results: no irritation;
(5) detection results of accumulative toxicity test: the continuous concentration coefficient is greater than 5, and the accumulation is weak;
therefore, the liquid dressing is non-toxic and non-corrosive, so that the application requirement of skin can be met, and the treatment comfort level is ensured.
The application method of the liquid dressing applied to superficial wound surfaces and peripheral skin care comprises the following steps:
(1) firstly, preparing corresponding liquid dressing;
(2) dipping and soaking the liquid dressing prepared in the step (1) by using a cotton swab, then coating the liquid dressing on the affected part by using the cotton swab, and applying the cotton swab dipped with the liquid dressing on the affected part and pressing for 3-8 minutes. When the affected part is condyloma acuminatum and herpes, the pressing time is 3 to 5 minutes. When the wound surface is verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris, the pressing time is 5 to 8 minutes. Thereby ensuring targeted therapy to ensure corresponding therapeutic effect and therapeutic comfort.
(3) Daubing the surface of an affected part with erythromycin;
(4) a single coating operation is completed.
The operation frequency of the step (2) is once a day when the affected part is condyloma acuminatum and herpes, and the operation frequency of the step (2) is twice a day when the affected part is common wart, flat wart, filiform wart and plantar wart. Until the affected part is healed, the corresponding superficial wound surface such as herpes and the like can be used according to the specific disease diagnosis state and the guidance suggestion of a doctor so as to ensure the corresponding relation between treatment and disease. The liquid dressing can be used according to the guidance of doctors, and is normal when the liquid dressing has stabbing pain or whitening, and patients with severe symptoms can be matched with antiviral oral medicines. In addition, the liquid dressing follows homeopathic principles and thus has an activating effect, and individual patients can cause potential virus outbreaks, which is normal. In the application process, the affected part can generate pruritus after the wart body falls off, the process is that the new skin grows normally, and the dosage of the patient can be reduced at the moment to continue normal use. The liquid dressing component can activate a self-healing system of an organism for viruses, form an isolation protective zone while killing the viruses, block the infection of the viruses on cells, upgrade the immunity of a collective to the viruses and generate specific antibodies. In addition, the liquid dressing can realize the promotion of an immune system, repair skin mucous membrane and ensure that the disease is not easy to relapse.
The above-mentioned embodiments are intended to illustrate the objects, technical solutions and advantages of the present invention in further detail, and it should be understood that the above-mentioned embodiments are only exemplary embodiments of the present invention and are not intended to limit the present invention, and any modifications, equivalents, improvements and the like made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (4)
1. A liquid dressing applied to superficial wound surfaces and peripheral skin care is characterized by comprising the following components in percentage by mass: 60 to 81.7 percent of dry distillation liquid of hawthorn seeds, 10 to 18 percent of acetic acid, 6 to 17 percent of heptaldehyde, 0.6 to 1.8 percent of dimethoxyphenol, 0.8 to 1.5 percent of mint essence and 0.9 to 1.7 percent of aloe.
2. A use method of a liquid dressing applied to superficial wound surfaces and peripheral skin care is characterized by comprising the following operation steps:
(1) preparing a liquid dressing according to the proportion of the liquid dressing applied to superficial wounds and peripheral skin care in claim 1 or 2;
(2) dipping and soaking the liquid dressing prepared in the step (1) by using a cotton swab, coating the liquid dressing on an affected part by using the cotton swab, and applying the cotton swab dipped with the liquid dressing on the affected part and pressing for 3-8 minutes;
(3) daubing the surface of an affected part with erythromycin;
(4) a single coating operation is completed.
3. The liquid dressing applied to the superficial wound surface and the peripheral skin care in the step (2), wherein the affected part comprises condyloma acuminatum, herpes, verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris, the pressing time is 3 to 5 minutes when the affected part comprises condyloma acuminatum and herpes, and the pressing time is 5 to 8 minutes when the wound surface comprises verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris.
4. The liquid dressing applied to the superficial wound surface and the peripheral skin care of claim 3, wherein the operation frequency of the step (2) is once a day when the affected part is condyloma acuminatum and herpes, and the operation frequency of the step (2) is twice a day when the wound surface is verruca vulgaris, verruca plana, verruca filiformis and verruca plantaris.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010678719.6A CN111821363A (en) | 2020-07-15 | 2020-07-15 | Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010678719.6A CN111821363A (en) | 2020-07-15 | 2020-07-15 | Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111821363A true CN111821363A (en) | 2020-10-27 |
Family
ID=72922848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010678719.6A Pending CN111821363A (en) | 2020-07-15 | 2020-07-15 | Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111821363A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112494554A (en) * | 2020-12-28 | 2021-03-16 | 张晓琼 | A pure plant extractive solution for preventing and treating skin and mucosa diseases caused by human papilloma virus infection |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1182601A (en) * | 1996-11-20 | 1998-05-27 | 晏晟 | Keyoulin sterilizing bactericide |
| CN1182538A (en) * | 1996-11-20 | 1998-05-27 | 韩林 | Method for extracting disfection biocide from hawthorn nut |
| CN1366030A (en) * | 2002-02-11 | 2002-08-28 | 石易 | Sanitary lotion prepared from fractional oil of haw kernel and its preparing process |
| CN111135217A (en) * | 2020-01-17 | 2020-05-12 | 苏州秀欣生物科技有限公司 | Scalp repair liquid and application method thereof |
-
2020
- 2020-07-15 CN CN202010678719.6A patent/CN111821363A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1182601A (en) * | 1996-11-20 | 1998-05-27 | 晏晟 | Keyoulin sterilizing bactericide |
| CN1182538A (en) * | 1996-11-20 | 1998-05-27 | 韩林 | Method for extracting disfection biocide from hawthorn nut |
| CN1366030A (en) * | 2002-02-11 | 2002-08-28 | 石易 | Sanitary lotion prepared from fractional oil of haw kernel and its preparing process |
| CN111135217A (en) * | 2020-01-17 | 2020-05-12 | 苏州秀欣生物科技有限公司 | Scalp repair liquid and application method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 孟凡红，等: "《单味中药临床应用新进展》", 31 May 2007, 人民卫生出版社 * |
| 李维玲,等: "红核妇洁洗液产后会阴伤口护理的随机对照研究", 《中国医药指南》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112494554A (en) * | 2020-12-28 | 2021-03-16 | 张晓琼 | A pure plant extractive solution for preventing and treating skin and mucosa diseases caused by human papilloma virus infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO326139B1 (en) | Composition comprising a plant chemical concentrate of Echinacea purpurea and benzalkonium chloride. | |
| US10478463B2 (en) | External-use medicament for cleaning and care of the ovaries, vagina, and vulva | |
| CN111821363A (en) | Liquid dressing applied to superficial wound surface and peripheral skin care and application method thereof | |
| US4049798A (en) | Method for the treatment of Herpes Simplex | |
| CN106619987A (en) | Externally-applied agent for prevention and treatment of pruritus and eczema at female sensitive position | |
| US20040109899A1 (en) | Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases | |
| SAMS et al. | Topical treatment with sulfathiazole | |
| CN102485236B (en) | Medicine composition for treating burns, scalds, carbuncle, furuncle, furunculosis, and herpes zoster | |
| CN103690903A (en) | Compound traditional Chinese medicine preparation for treating trauma diseases such as burn, scald, bedsore and the like | |
| CN102293880B (en) | External Chinese herbal preparation for treating bedsore and preparation method thereof | |
| CN101612203B (en) | Traditional Chinese medicine composition used for treating pointed condyloma and application thereof | |
| CN104721384A (en) | Convergence ointment | |
| CN103550327A (en) | Preparation method of medicament for healing of wound | |
| CN111437343B (en) | Inflammation-diminishing and pain-relieving composition, carthamus tinctorius inflammation-diminishing and pain-relieving liquid and preparation method thereof | |
| JPS63501422A (en) | How to treat genital and oral herpes | |
| CN101966232B (en) | Traditional Chinese medicine for treating burn | |
| CN101978968B (en) | Medicament for treating tympanitis | |
| Lain | Sulfanilamide in Glycerin in the Local Treatment for Pyodermas | |
| CN101352463B (en) | Plaster for treating parotiditis | |
| RU2173155C1 (en) | Wound-healing, anti-inflammatory and anti-infectious medicinal preparation | |
| CN100558363C (en) | A kind of pharmaceutical composition for the treatment of condyloma acuminatum | |
| CN106138124A (en) | The new purposes method of Flos abelmoschi manihot total flavones treatment gynaecopathia (vaginitis, cervicitis, cervical erosion) | |
| CN105168632A (en) | Traditional Chinese medicinal plastics for promoting healing of wound of cesarean section and preparation method thereof | |
| CN108339092A (en) | A kind of formula for controlling lumbar sprain | |
| Mirunaleni et al. | MANAGEMENT OF EXTRAGENITAL CUTANEOUS WARTS THROUGH SIDDHA MEDICINE-A CASE REPORT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201027 |